References
- Baykal A, Iskit AB, Kaynaroglu V. Guc MO, Sayek I, Sanac Y. Effects of adrenaline or endotoxin tolerance Eur J Surg 166 states on mesenteric blood flow in endotoxemia. Aust N Z J Surg 1999; 69: 134–137.
- Baykal A, Kavuklu B, Iskit AB, Gue MO, Hascelik G, Sayek I. An experimental study of the effect of nitric oxide inhibition on mesenteric blood flow and IL-10 levels in endotoxin challenge. World J Surg.: in press.
- Baykal A, Kaynarogiu V. Iskit AB, et al. Adrenaline tolerance does not prevent bacterial translocation in a murine bum model. Int Surg 2000; 85: 18–22.
- Berg DJ, Kuhn R, Rajewsky K, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not to endotoxin tolerance. J Clin Invest 1995; 96: 2339–2347.
- Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero JM. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20: 205–210.
- Boczkowski J, Philip I, Tedgui A, et al. Effects of inhibition of nitric oxide synthesis on TNF alpha serum levels in E coli endotoxemic rats. Life Sci 1995; 57: PL147–152.
- Bouvier C, Gue MO, Furman BL, Parrat JR. Platelet activating factor impairs responses to noradrenaline in the anesthetized rat but does not mediate endotoxin-induced hyporeactivity. Circ Shock 1991; 42: 14–19.
- Crawford EK, Ensor JE, Kalvakolanu I, Hasday JD. The role of 3' poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J Biol Chem 1997; 272: 21120–21127.
- Cunnane SC, Horrobin DF, Manku MS, Oka M. The vascular response to zinc varies seasonally: effect of pinealectomy and melatonin. Chronobiologia 1980; 7: 493–503.
- Cunnane SC, Manku MS, Oka M, Horrobin DF. Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Can J Physiol Pharmacol 1980; 58: 287–293.
- Doolen S, Krause DN, Dubocovich ML, Ducldes SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 1998; 345: 67–69.
- Ferreira SA, Rollag MD, Glass JD. Pharmacokinetics of extracellular melatonin in Siberian hamster forebrain. Brain Res 1996; 733: 318–320.
- Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet J-C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 1990; 171: 562–565.
- Gardiner SM, Kemp PA, March JE, Bennett T. Cardiac and regional hemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 1995; 116: 2005–2016.
- Gilad E, Wong HR, Zingarelli B, et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibi-tion of NFkappaB activation. FASEB J 1998; 12: 685–693.
- Gue MO, Furman BL, Parratt JR. Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 1990; 101: 913–919.
- Gue MO, Furman BL, Parratt JR. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin treated pithed rats. Eur J Pharmacol 1992; 224: 63–69.
- Gue MO, Gray GA, Furman BL, Parratt JR. Endotoxin induced impairment of vasodepressor responses in the pithed rat. Eur J Pharmacol 1991; 204: 63–70.
- Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporespon-siveness to catecholamines in septic rats. Am J Physiol 1993; 1264: H660–H663.
- Im SY, Han SJ, Ko HM, et al. Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur J Immunol 1997; 27: 2800–2804.
- Julou-Schaffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet J-C. Loss of vascular responsiveness induced by endotoxin involves L-Arginine pathway. Am J Physiol 1990; 259: H1038–H1043.
- Krause DN, Barrios VE, Ducldes SP. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 1995; 276: 207–213.
- Maestroni GJM, Conti A. The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist (s) with immunoenhancing and anti-stress properties. J Neuroimmunol 1990; 28: 167–176.
- Maestroni GJM, Conti A, Pierpaoli W. The pineal gland and the circadian opiatergic immunoregulatory role of melatonin. Ann NY Acad Sci 1987; 496: 67–77.
- Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55: 271.
- Pioli C, Caroleo MC, Nistico G, Doria G. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol 1993; 15: 463–468.
- Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65: 430–442.
- Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Physio-logical concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994; 55: PL455–460.
- Sullivan DJ, Shelby J, Shao Y, Afileck DG, Hinson DM, Barton RG. Melatonin and a 21-Aminosteroid attenuate shock after hemorrhage but differentially affect serum cytokines. J Surg Res 1996; 64: 13–18.
- Thiemmerman C, Vane JR. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591–595.
- Viswanathan M, Laitinen JT, Saavedra JM. Vascular melatonin receptors. Biol Signals 1993; 2: 221–227.
- Wichmann MW, Haisken JM, Ayala A, Chaudry IH. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J Surg Res 1996; 65: 109–114.
- Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH. Melatonin administration attenuates de-pressed immune functions after trauma-hemorrhage. J Surg Res 1996; 63: 256–262.
- Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D. Pharmacokinetics and oral bioavailability of exogen-ous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997; 22: 45–51.
- Zanetti G, Heumann D, Gerain J, et al. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 1992; 148: 1890–1897.